Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
An increasing demand for gene therapies is focusing the industry on enhancing production capabilities, transitioning from ...
News-Medical.Net on MSN
Researchers develop a versatile tool for controlling gene activity
Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...
A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...
For decades, synthetic biologists have been developing gene circuits that can be transferred into cells for applications such as reprogramming a stem cell into a neuron or generating a protein that ...
Scientists have successfully created immature human egg-like cells from skin-derived stem cells, a significant step in ...
Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for ...
A red quarter of a circle with the words 'The Quarter Mark' beside it. A year-long series looking back on the most significant moments of the past 25 years, how they changed our world, and how they ...
Bio-Gene Technology Ltd. ( ($AU:BGT) ) has shared an announcement. Bio-Gene Technology Limited reported significant progress in Q1 FY26, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback